• OPEN AN ACCOUNT
Indian Indices
Nifty
25,898.55 140.55
(0.55%)
Sensex
84,818.13 426.86
( 0.51%)
Bank Nifty
59,209.85 249.45
( 0.42%)
Nifty IT
38,097.00 307.10
( 0.81%)
Global Indices
Nasdaq
48,074.52 493.22
(1.04%)
Dow Jones
6,906.36 44.85
(0.65%)
Hang Seng
50,166.54 -436.26
(-0.86%)
Nikkei 225
9,710.82 55.29
(0.57%)
Forex
USD-INR
89.93 -0.16
(-0.18%)
EUR-INR
104.64 -0.26
(-0.25%)
GBP-INR
119.76 -0.28
(-0.23%)
JPY-INR
0.58 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Norris Medicines Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524414
INE744C01029
-15.8200926
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
14.5
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

As on: Dec 11, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
14.50 0.00 130 0.00
Stock Price Details
Open Price() 14.57
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 14.57
Today's Low () 14.43
52-Week High () 24.65
152-Week Low () 14
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 0
Book Value -15.8200926
Market Cap (.Cr) 14.50
Face Value 10
Market Lot 1
AGM Date Sep
Book Closure Date Dec
ISIN No. INE744C01029


News
Norris Medicines reports standalone net loss of Rs 0.72 crore in the September 2025 quarter
Norris Medicines to table results
Norris Medicines Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Norris Medicines Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Norris Medicines to convene AGM
Norris Medicines reports standalone net loss of Rs 0.31 crore in the June 2025 quarter
Norris Medicines Ltd - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
Norris Medicines Ltd - Outcome Of Board Meeting Held On Thursday 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
Norris Medicines to conduct board meeting
Norris Medicines Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
More
Corporate Details
Incoporation Year   : 1990
Chairman : Vimal D Shah
Bussiness Group :
Registered Office
Norris Medicines Ltd
Plot No 801/P & 802,
GIDC Industrial Estate,
Ankleshwar,
Gujarat-393002
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-2646-223462/227530
Fax:91-2646-250126
Fax:91-22-66317458
E-Mail : norrismedicines@gmail.com; contact@norrispharma.co
URL : http://www.norrispharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
No Data Found...!
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi